• NetraMark reported fiscal 2026 new contract bookings of about C$3.42 million, lifting total booked contract value to about C$3.74 million.
• Bookings rose 645% versus the prior annual high of about C$458,000.
• A Phase 2 clinical-trial dataset analysis contract marked its first commercial project sourced through a CRO partner.
• Revenue recognized in the first nine months of fiscal 2026 rose 45% to C$559,564.
• About C$3.18 million of booked contract value remained unrecognized, tied to future work under signed contracts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NetraMark Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608200700PRIMZONEFULLFEED9813194) on August 20, 2026, and is solely responsible for the information contained therein.